INDOUS
Start SIP
Invest Now
Start SIP in INDOUS
Performance
- Low
- ₹142
- High
- ₹151
- 52 Week Low
- ₹105
- 52 Week High
- ₹224
- Open Price₹144
- Previous Close₹146
- Volume106,795
- 50 DMA₹128.62
- 100 DMA₹131.82
- 200 DMA₹150.75
Investment Returns
- Over 1 Month + 35.61%
- Over 3 Month + 22.81%
- Over 6 Month -0.07%
- Over 1 Year -31.04%
Smart Investing Starts Here Start SIP with Indo US Bio-Tech for Steady Growth!
Indo US Bio-Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20.4
- PEG Ratio
- 1.5
- Market Cap Cr
- 302
- P/B Ratio
- 3.5
- Average True Range
- 7.95
- EPS
- 7.4
- Dividend Yield
- 0
- MACD Signal
- 4.12
- RSI
- 71.39
- MFI
- 77.02
Indo US Bio-Tech Financials
Indo US Bio-Tech Technicals
EMA & SMA
Current Price
₹150.72
+
4.48
(3.06%)
- Bearish Moving Average 1
- Bullish Moving Average 15
- 20 Day
- ₹133.56
- 50 Day
- ₹128.62
- 100 Day
- ₹131.82
- 200 Day
- ₹150.75
Resistance and Support
147.84
- R3 163.02
- R2 157.00
- R1 153.86
- S1 144.70
- S2 138.68
- S3 135.54
Indo US Bio-Tech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-21 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-10-14 | Others | Inter-alia, to consider 1. Re-appointment of M/s. Gautam N Associates as a Statutory Auditors of the Company. 2. Approve Notice of Postal Ballot. 3. Other business matters. per share(2.5%)Interim Dividend |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results |
Indo US Bio-Tech F&O
About Indo US Bio-Tech
- NSE Symbol
- INDOUS
- BSE Symbol
- 541304
- Managing Director
- Mr. Jagdish Ajudia
- ISIN
- INE250Z01010
Similar Stocks to Indo US Bio-Tech
Indo US Bio-Tech FAQs
Indo US Bio-Tech share price is ₹150 As on 22 February, 2026 | 19:05
The Market Cap of Indo US Bio-Tech is ₹302.2 Cr As on 22 February, 2026 | 19:05
The P/E ratio of Indo US Bio-Tech is 20.4 As on 22 February, 2026 | 19:05
The PB ratio of Indo US Bio-Tech is 3.5 As on 22 February, 2026 | 19:05
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.